Literature DB >> 217888

Pseudocorpus luteum insufficiency: a local defect of progesterone action on endometrial stroma.

D W Keller, W G Wiest, F B Askin, L W Johnson, R C Strickler.   

Abstract

A 23-yr-old woman whose initial complaint was infertility demonstrated glandular stromal dissociation with failure of the endometrial stroma to undergo pseudodecidualization in repeated endometrial biopsies taken late in the luteal phase. As the clinical presentation was consistent with the inadequate corpus luteum syndrome, hormone measurements were performed. The endometrial biopsy was abnormal during cycles in which the serum pattern of progesterone, estradiol, FSH, and LH was normal. Exogenous progesterone did not correct the abnormality. The patient, by in vitro studies, has approximately one half the number of high affinity progesterone-binding sites in the cytosol fraction of her endometrium compared to preparations from two normal control subjects. Since her cytosol-binding protein was qualitatively identical to two control subjects, the incomplete maturation of her endometrial stroma may represent an absence or reduced number of stromal cytosol receptors and/or a resistance to specific hormone action in an individual target tissue.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217888     DOI: 10.1210/jcem-48-1-127

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Status of type-II glucocorticoid receptors in tissues of adrenalectomized rats.

Authors:  P P Golikov
Journal:  Neurosci Behav Physiol       Date:  1986 Jul-Aug

2.  Specific glucocorticoid receptors of human muscle cytosol.

Authors:  P P Golikov
Journal:  Neurosci Behav Physiol       Date:  1986 May-Jun

3.  An immunohistochemical study of metroplastic surgical specimens from patients with a septate uterus.

Authors:  Tsunehisa Makino; Li-Yi Cai; Shun-Ichiro Izumi; Masanori Yasuda
Journal:  Reprod Med Biol       Date:  2011-08-03

4.  Effect of steroid hormones on the template activity of DNA and glucocorticoid-receptor interaction.

Authors:  P P Golikov; A S Bobkova
Journal:  Neurosci Behav Physiol       Date:  1982 Sep-Oct

5.  Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms.

Authors:  G P Chrousos; D Renquist; D Brandon; C Eil; M Pugeat; R Vigersky; G B Cutler; D L Loriaux; M B Lipsett
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Subfertility linked to combined luteal insufficiency and uterine progesterone resistance.

Authors:  Toshihiro Konno; Amanda R Graham; Lea A Rempel; Jennifer K Ho-Chen; S M Khorshed Alam; Pengli Bu; M A Karim Rumi; Michael J Soares
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

7.  Correlation between endometrial biopsy and luteal phase plasma progesterone in women complaining for couple infertility.

Authors:  I Noci; V Dubini; R Piacentini; M Colafranceschi; G Taddei; G Scarselli
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

8.  Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.

Authors:  G P Chrousos; A Vingerhoeds; D Brandon; C Eil; M Pugeat; M DeVroede; D L Loriaux; M B Lipsett
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

9.  Rethinking progesterone regulation of female reproductive cyclicity.

Authors:  Kaiyu Kubota; Wei Cui; Pramod Dhakal; Michael W Wolfe; M A Karim Rumi; Jay L Vivian; Katherine F Roby; Michael J Soares
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

10.  SOX4 facilitates PGR protein stability and FOXO1 expression conducive for human endometrial decidualization.

Authors:  Pinxiu Huang; Wenbo Deng; Haili Bao; Zhong Lin; Mengying Liu; Jinxiang Wu; Xiaobo Zhou; Manting Qiao; Yihua Yang; Han Cai; Faiza Rao; Jingsi Chen; Dunjin Chen; Jinhua Lu; Haibin Wang; Aiping Qin; Shuangbo Kong
Journal:  Elife       Date:  2022-03-04       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.